100
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Modelling of serotonin reuptake inhibitory and histamine H3 antagonistic activity of piperazine and diazepane amides: QSAR rationales for co-optimization of the activity profiles

, , , &
Pages 365-383 | Received 12 Jun 2010, Accepted 21 Nov 2010, Published online: 18 May 2011
 

Abstract

Selective human serotonin reuptake transporter (hSERT) inhibition is the first line of treatment to deal with the depression. In clinical practice for managing depression, the stimulants are co-prescribed to overcome cognitive impairment and fatigue. Recently, histamine H3 antagonists with serotonin reuptake inhibition activity have been proposed as alternative approach for the treatment of depression. In this context, a QSAR study of hSERT inhibitory and H3 antagonistic activity of piperazine and diazepane amide derivatives has been carried out using the combinatorial protocol in multiple linear regression (CP-MLR) with 0D- to 2D-Dragon descriptors. The derived QSAR models have provided a rational approach for the development of new piperazine and diazepane amide derivatives as hSERT inhibitors and H3 antagonists. In a concomitant partial least-squares (PLS) analysis of the hSERT and histamine H3 activities, the fraction contributions of identified descriptors revealed their importance in modulating these activities. The PLS analysis of other biological endpoints, namely hNET, hDAT, and histamine H3 activity in functional assay (H3pA2) of these analogues with the identified descriptors has further highlighted their scope in modulating these activities.

Acknowledgements

Authors express their sincere gratitude to their Institutions for providing necessary facilities to complete this study. KS thanks UGC, Bhopal India for financial support in the form of TRF. CDRI communication number 8003.

Supporting information

The complete dataset of molecular descriptors of structure database of , loadings, PLS weights and sensitivity of independent and dependent descriptors of the PLS models is available via the Supplementary Content tab on the article's online page at http://dx.doi.org/10.1080/1062936X.2011.569895.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.